Jackson Acquisition Co II (JACS) is asking shareholders to approve amendments that would let its board extend the deadline for completing an initial business combination from December 11, 2026, by up to twelve one-month periods, through December 11, 2027 (or within 36 months from the consummation of the IPO). The extension is not automatic: both amendments must be approved and implemented, after which the board could elect each monthly extension without another shareholder vote.
For each elected month, RJ Healthcare SPAC II, LLC (the Sponsor), or its affiliates or designees, would deposit the lesser of $250,000 and $0.02 for each Public Share not redeemed, in exchange for a non-interest-bearing, unsecured promissory note. A missed payment can be cured within 30 days; otherwise, the Company would be required to liquidate the Trust Account. Public shareholders may redeem shares if the Articles Amendment is implemented. The meeting is scheduled for November 20, 2026; approval requires at least two-thirds of shareholders voting for the extension amendment and 65% of issued and outstanding ordinary shares for the trust amendment.
Meteora Capital, LLC and its managing member, Vik Mittal, report beneficial ownership of 528,112 shares of Jackson Acquisition Co II Class A Common Stock on a Schedule 13G/A. This represents 2.22% of the class. All these shares are held through Meteora-managed funds, with shared voting and dispositive power over the full amount and no sole power. The filers state they are deemed to own 5 percent or less of the class and expressly note that the filing should not be construed as an admission of beneficial ownership for all purposes.
Jackson Acquisition Company II is a Cayman Islands-based blank check company seeking a healthcare-focused Business Combination. As of June 30, 2026, it held $246,845,170 in a U.S. Treasury-backed Trust Account and total assets of $247,289,503, generating interest income but no operating revenue.
For the three and six months ended June 30, 2026, it reported net income of $1,980,048 and $3,949,131, driven by trust interest of $2,164,627 and $4,301,982, partially offset by general and administrative expenses. Public Class A shares are redeemable at $10.73 per share, with 23,000,000 shares classified as temporary equity.
The company reported cash outside the Trust of $358,338 and a working capital deficit of $132,101. Management disclosed that the need to complete a Business Combination by December 11, 2026 or liquidate, together with expected costs, raises substantial doubt about its ability to continue as a going concern. It also outlined NYSE listing risk after falling below the 300 public shareholder requirement, with a cure plan accepted through August 6, 2027.
Jackson Acquisition Co II ownership filing: Meteora Capital, LLC and Vik Mittal report 1,219,744 shares of Class A Common Stock, representing 5.11% of the class. The filing lists shared voting and dispositive power over these shares. The statement is signed by Vik Mittal on 05/15/2026.
Jackson Acquisition Company II, a healthcare-focused SPAC, reported net income of $1,969,083 for the quarter ended March 31, 2026, mainly from interest on marketable securities in its Trust Account. Interest income was $2,137,355, while general and administrative costs were $168,272.
The Trust Account held $244,680,543 invested in U.S. Treasury-focused money market funds, and cash outside the trust was $393,467 to fund ongoing search and operating costs. Management highlights substantial doubt about the company’s ability to continue as a going concern if no Business Combination is completed by December 11, 2026.
The company also discloses a NYSE notice received on February 6, 2026 for non-compliance with the 300 public shareholders requirement and has submitted a remediation plan. If compliance is not restored, its securities could be delisted, which could complicate completing a Business Combination.
AQR-affiliated entities reported beneficial ownership of 1,162,562 Class A ordinary shares of Jackson Acquisition Co II, representing 4.88% of the class. The filing lists AQR Capital Management, LLC, AQR Capital Management Holdings, LLC, and AQR Arbitrage, LLC as reporting persons and shows shared voting and dispositive power over the shares.
The schedule is an amendment labeled Amendment No. 2 and is signed by an authorized signatory on behalf of the three AQR entities.
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC report shared beneficial ownership of Class A ordinary shares of JACKSON ACQUISITION CO II. The filing lists 745,710 shares with shared voting and dispositive power, representing 3.1% of the class as shown on the cover page. The submission is a joint Schedule 13G/A amendment executed by authorized signatory Ameen Soetan.
Jackson Acquisition Company II is a Cayman Islands-based blank check company focused on completing an initial business combination, primarily targeting healthcare services and healthcare technology, though it may pursue opportunities in other sectors.
The company completed an IPO of 23,000,000 units at $10.00 each, plus 840,000 private placement units, and placed approximately $232.3 million into a trust account for the benefit of public shareholders. As of December 31, 2025, it reports about $233.3 million available for a business combination, assuming no redemptions and after up to $9.2 million of marketing fees, before transaction costs.
Public shareholders may redeem their Class A ordinary shares at a price initially anticipated to be about $10.10 per share in connection with a business combination or certain charter amendments, subject to net tangible asset and other conditions. If no business combination is completed by December 11, 2026, the company will redeem all public shares and liquidate the trust. The SPAC is an emerging growth and smaller reporting company, which allows reduced disclosure and delayed adoption of some accounting standards.
HGC Investment Management Inc. filed a Schedule 13G reporting a passive ownership stake in Jackson Acquisition Company II Class A common stock. HGC reports beneficial ownership of 1,475,200 shares, representing 6.19% of the class as of 12/31/2025, with sole voting and dispositive power over these shares.
The filing explains that HGC, a Canadian investment manager, holds the shares on behalf of The HGC Fund LP, which has the right to receive dividends and sale proceeds. HGC certifies the position was acquired and is held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Bank of Montreal and its affiliates filed an amended ownership report showing they now beneficially own 0 Class A ordinary shares of Jackson Acquisition Co II, representing 0% of the class as of December 31, 2025. The filing lists Bank of Montreal, Bank of Montreal Holding Inc., and BMO Nesbitt Burns Inc. as reporting persons, each with no sole or shared voting or dispositive power over the issuer’s shares. They certify that any securities referenced were acquired and are held in the ordinary course of business and not to change or influence control of the issuer or to participate in any control-related transaction.